Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicinal composition for lowering blood lipid level

A composition and drug technology, applied in the direction of drug combination, active ingredients of heterocyclic compounds, pharmaceutical formulations, etc.

Inactive Publication Date: 2005-10-26
SANKYO CO LTD
View PDF7 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] Concomitant use of bile acids with statins further reduces cholesterol concentrations in bile and is therefore consistent with the usefulness of gallstone-dissolving therapy, with no opposing views and data
[0013] On the other hand, in known documents that report the effect on blood lipids when statin drugs are used in combination with bile acids, the results are different from the above-mentioned evaluation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for lowering blood lipid level
  • Medicinal composition for lowering blood lipid level
  • Medicinal composition for lowering blood lipid level

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] Example 1 tablet

[0074] In 6 tablets (mg)

In 6 tablets (mg)

In 6 tablets (mg)

Atorvastatin Calcium

Simvastatin

ursodeoxycholic acid

magnesium oxide

Magnesium aluminosilicate

Crystalline Cellulose

corn starch

Hydroxypropyl Cellulose

Croscarmellose Sodium

(croscarmellose sodium)

Magnesium stearate

Triacetin

lactose

20

-

300

400

140

120

140

60

15

25

6

Appropriate amount

-

10

300

400

140

120

140

60

15

25

6

Appropriate amount

10

5

300

400

140

120

140

60

15

25

6

Appropriate amount

total

1200

1200

1200

[0075] (2) Preparation method

[0076] The weight of the above ingredients was taken, and tablets were prepared according to the Japanese Pharmacopoeia General Chapter tablet item.

Embodiment 2

[0077] Example 2 fine granules

[0078] (1) Ingredients

[0079] 3 packs (mg)

3 packs (mg)

3 packs (mg)

Atorvastatin Calcium

Simvastatin

ursodeoxycholic acid

magnesium oxide

Magnesium aluminosilicate

Refined white sugar

Stevia Extract Product

corn starch

Polysorbate 80

Magnesium stearate

lactose

20

-

300

400

140

1400

15

1200

80

25

Appropriate amount

-

10

300

400

140

1400

15

1000

80

25

Appropriate amount

10

5

300

400

140

1400

15

1100

80

25

Appropriate amount

total

4300

4300

4300

[0080] (2) Preparation method

[0081] The weight of the above ingredients was taken, and the fine granules were prepared according to the granules item in the Japanese Pharmacopoeia General Rules of Preparations.

Embodiment 3

[0082] Example 3 Capsules

[0083] In 6 capsules (mg)

In 6 capsules (mg)

In 6 capsules (mg)

Atorvastatin Calcium

Simvastatin

ursodeoxycholic acid

magnesium oxide

corn starch

Polysorbate 80

Magnesium stearate

lactose

capsule

20

-

300

400

600

50

25

Appropriate amount

480

-

10

300

400

400

50

25

Appropriate amount

480

10

5

300

400

500

50

25

Appropriate amount

480

total

2300

2300

2300

[0084] (2) Preparation method

[0085] Take the above ingredients and weigh them, prepare fine granules based on the Japanese Pharmacopoeia General Rules granules, and fill them into capsules to prepare hard capsules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides an excellent medicinal composition for lowering blood lipid level. The medicinal composition containing an HMG-CoA reductase inhibitor and bile acids.

Description

technical field [0001] The present invention relates to a pharmaceutical composition for lowering blood lipids containing HMG-CoA reductase inhibitors and bile acids. Background technique [0002] Statins are drugs that specifically and competitively inhibit HMG-CoA reductase in vivo and lower blood cholesterol levels. [0003] In addition, the known effects of bile acid components include: improving cholestasis, dissolving cholesterol-like gallstones, inhibiting cholesterol absorption from the intestine, etc. ぅ). [0004] On the other hand, in some literatures, the combined use of statins and bile acid components is mostly about the therapy of dissolving cholesterol gallstones, and others have also reported about the bile flowing out to the duodenum due to certain reasons. Literature on the treatment of induced biliary liver disease, biliary cirrhosis, cholestatic jaundice, secondary hypercholesterolemia, etc. [0005] Examples of combined use of statins and bile acid com...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/191A61K31/22A61K31/351A61K31/40A61P3/06A61P9/10
CPCA61K31/351A61K31/22A61K31/191A61K31/40A61P3/06A61P9/10
Inventor 近藤达仁高木郁夫中山正人鸟住保博
Owner SANKYO CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products